VRC-FLUDNA047-00-VP

DNA influenza vaccine (trivalent) · National Institute of Allergy and Infectious Diseases (NIAID)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VRC-FLUDNA047-00-VP, covering 2017-07-02 to 2017-07-02. Get the full timeline:

Most recent: Clinical Trial Update: VRC 307: A Double-Blind, Randomized Phase I Study of the Safety and Immunogenicity of a Prime-Boost Schedule of the Investigational DNA Trivalent Influenza Vaccine, VRC-FLUDNA047-00-VP, Followed by the 2008/2009 Seasonal Influenza Trivalent Inactivat... [Phase 1]

See pricing